Home › Free Stock Grades › EBS
Emergent BioSolutions Inc. (EBS) Stock Grade
EBS · Healthcare
B-
Market Cap
$354.0M
P/E Ratio
12.6
Revenue Growth (YoY)
-28.8%
Net Margin
7.1%
Return on Equity
10.1%
Dividend Yield
None
About Emergent BioSolutions Inc.'s fundamentals
Emergent BioSolutions is a specialty and generic drug manufacturer with a market capitalization of $354.0 million and a P/E ratio of 12.6. The company is experiencing significant headwinds, with revenue declining 28.8% year-over-year, though it maintains a net profit margin of 7.1%, indicating operational profitability despite the revenue contraction. Return on equity stands at 10.1%, and the company does not currently pay a dividend.